TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-1.54%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$216M
AUM Growth
+$216M
(+4.7%)
Cap. Flow
+$4.02M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
99.94%
Holding
14
New
–
Increased
2
Reduced
1
Closed
2
Top Buys
| 1 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$7.99M |
| 2 |
Heron Therapeutics
HRTX
|
$6.29M |
Top Sells
| 1 |
MannKind Corp
MNKD
|
$7.24M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$2.95M |
| 3 |
Phio Pharmaceuticals
PHIO
|
$78K |
Sector Composition
| 1 | Healthcare | 48.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Heron Therapeutics
HRTX
$207M
| $60.6M | 28.07% |
4,919,625
+510,638
| +12% | +$6.29M |
|
|
SLXP
2
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $37M | 17.14% |
300,000
| – | – |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $15.8M | 7.33% |
1,000,000
| – | – |
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $11.3M | 5.25% |
182,300
| – | – |
|
|
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $8.1M | 3.75% |
881,907
+870,688
| +7,761% | +$7.99M |
|
|
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.77M | 2.67% |
288,432
-147,411
| -34% | -$2.95M |
|
|
ECYT
7
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $3.07M | 1.42% |
465,763
| – | – |
|
|
DNDN
8
DELISTED
DENDREON CORPORATION
DNDN
| $128K | 0.06% |
55,548
| – | – |
|
|
9
MannKind Corp
MNKD
$1.41B
| – | – |
-1,800,000
| Closed | -$7.24M |
|
|
10
Phio Pharmaceuticals
PHIO
$11.3M
| – | – |
-18,245
| Closed | -$78K |
|
|
AMBI
11
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $0 | ﹤0.01% |
46
| – | – |
|